A 37-year-old Menkes disease patient-Residual ATP7A activity and early copper administration as key factors in beneficial treatment
Tümer Z, Petris M, Zhu S, Mercer J, Bukrinski J, Bilz S, Baerlocher K, Horn N, Møller L. A 37-year-old Menkes disease patient-Residual ATP7A activity and early copper administration as key factors in beneficial treatment. Clin Genet 2017; 92:548-553.
01.11.2017
A 37-year-old Menkes disease patient-Residual ATP7A activity and early copper administration as key factors in beneficial treatment
01.11.2017
Clin Genet 2017; 92:548-553
Tümer Z, Petris M, Zhu S, Mercer J, Bukrinski J, Bilz Stefan, Baerlocher K, Horn N, Møller L B
Weiter
